相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML
Zejuan Li et al.
BLOOD (2012)
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
Leonie J. M. Mekenkamp et al.
BMC CANCER (2012)
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
M. Pichler et al.
BRITISH JOURNAL OF CANCER (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
A Common Role for Various Human Truncated Adenomatous Polyposis Coli Isoforms in the Control of Beta-Catenin Activity and Cell Proliferation
Shree Harsha Vijaya Chandra et al.
PLOS ONE (2012)
Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity
Zhao-Qiu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
Ki-Hyuk Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours
S. Weidlich et al.
BRITISH JOURNAL OF CANCER (2011)
miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma
Cheng-Chieh Yang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2011)
Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM
Y. Wang et al.
ONCOGENE (2011)
Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma
Junfang Ji et al.
CELL AND BIOSCIENCE (2011)
Prox1 expression is negatively regulated by miR-181 in endothelial cells
Jan Kazenwadel et al.
BLOOD (2010)
A deep investigation into the adipogenesis mechanism: Profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/β-catenin signaling pathway
Limei Qin et al.
BMC GENOMICS (2010)
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
Marc Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma
Johannes H. Schulte et al.
NUCLEIC ACIDS RESEARCH (2010)
Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in EpCAM-Positive Hepatic Cancer Stem Cells
Junfang Ji et al.
HEPATOLOGY (2009)
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors
Martin Pichler et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
Lei Shi et al.
BRAIN RESEARCH (2008)
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
Astrid Lievre et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181
Yuri Pekarsky et al.
CANCER RESEARCH (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation
I Naguibneva et al.
NATURE CELL BIOLOGY (2006)
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
MicroRNAs modulate hematopoietic lineage differentiation
CZ Chen et al.
SCIENCE (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Metastatic renal carcinoma comprehensive prognostic system
J Atzpodien et al.
BRITISH JOURNAL OF CANCER (2003)
分享论文
